Daniel Benjamin Rosen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seminoma | 2 | 2023 | 136 | 1.620 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 808 | 1.120 |
Why?
|
Neoplasms, Second Primary | 2 | 2023 | 1060 | 1.010 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 496 | 0.600 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2020 | 812 | 0.460 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2565 | 0.380 |
Why?
|
Orchiectomy | 2 | 2023 | 468 | 0.380 |
Why?
|
Battered Women | 1 | 2006 | 36 | 0.270 |
Why?
|
Women's Health Services | 1 | 2006 | 88 | 0.260 |
Why?
|
Palliative Care | 1 | 2020 | 3644 | 0.250 |
Why?
|
Sex Offenses | 1 | 2006 | 357 | 0.200 |
Why?
|
Vulnerable Populations | 1 | 2006 | 718 | 0.180 |
Why?
|
Chemokine CXCL10 | 1 | 2022 | 311 | 0.180 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 299 | 0.180 |
Why?
|
Interleukin-18 | 1 | 2022 | 251 | 0.180 |
Why?
|
Interleukin-8 | 1 | 2022 | 705 | 0.160 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11262 | 0.150 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2023 | 1793 | 0.150 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 640 | 0.150 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 608 | 0.140 |
Why?
|
Pregnant Women | 1 | 2022 | 576 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2022 | 1528 | 0.140 |
Why?
|
Women's Health | 1 | 2006 | 2081 | 0.140 |
Why?
|
Disabled Persons | 1 | 2006 | 1210 | 0.140 |
Why?
|
Immunoglobulin Class Switching | 1 | 2018 | 289 | 0.140 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2018 | 648 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9442 | 0.120 |
Why?
|
DNA Replication | 1 | 2022 | 1428 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 633 | 0.110 |
Why?
|
Radiosurgery | 1 | 2021 | 1346 | 0.100 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8559 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 22389 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3215 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2023 | 81903 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2812 | 0.080 |
Why?
|
Cytokines | 1 | 2022 | 7453 | 0.070 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.060 |
Why?
|
Personal Autonomy | 1 | 2006 | 315 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10400 | 0.050 |
Why?
|
Karnofsky Performance Status | 1 | 2021 | 167 | 0.050 |
Why?
|
Telomere-Binding Proteins | 1 | 2022 | 122 | 0.050 |
Why?
|
Canada | 1 | 2006 | 2130 | 0.050 |
Why?
|
Humans | 7 | 2023 | 768970 | 0.040 |
Why?
|
Male | 3 | 2023 | 365203 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 30265 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39394 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1407 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2018 | 103 | 0.040 |
Why?
|
Adolescent | 2 | 2020 | 89244 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2018 | 249 | 0.030 |
Why?
|
DNA | 2 | 2022 | 7214 | 0.030 |
Why?
|
Social Support | 1 | 2006 | 2193 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54962 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59739 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2021 | 1277 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
Female | 3 | 2022 | 397515 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 60131 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2018 | 1148 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2054 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1369 | 0.020 |
Why?
|
Phosphorylation | 1 | 2022 | 8317 | 0.020 |
Why?
|
Adult | 2 | 2020 | 223851 | 0.020 |
Why?
|
Aged | 1 | 2020 | 171786 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5801 | 0.020 |
Why?
|
Chromatin | 1 | 2018 | 2981 | 0.020 |
Why?
|
Middle Aged | 1 | 2020 | 223737 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4794 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15604 | 0.010 |
Why?
|
Mice | 2 | 2022 | 82072 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22379 | 0.010 |
Why?
|
United States | 1 | 2006 | 73186 | 0.010 |
Why?
|
Animals | 2 | 2022 | 169335 | 0.010 |
Why?
|